Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
32.01
+0.31 (+0.98%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
↗
November 14, 2025
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.
Via
Benzinga
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss
↗
November 14, 2025
Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline.
Via
Chartmill
Topics
Earnings
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
November 14, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings
↗
November 14, 2025
Via
Benzinga
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Preview: Twist Bioscience's Earnings
↗
August 01, 2025
Via
Benzinga
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
Earnings Outlook For Twist Bioscience
↗
November 13, 2025
Via
Benzinga
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
November 04, 2025
Via
Benzinga
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
November 04, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 03, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From
Halper Sadeh LLC
Via
Business Wire
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
October 23, 2025
From
Twist Bioscience Corporation
Via
Business Wire
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
↗
October 20, 2025
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
↗
October 15, 2025
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Via
Benzinga
Topics
Artificial Intelligence
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
October 06, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design
October 02, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
September 03, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Collaborates with Synthetic Design Lab
September 02, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
August 19, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors
August 06, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
↗
August 05, 2025
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.
Via
Benzinga
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings
↗
August 04, 2025
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026.
Via
Benzinga
Twist Bioscience (TWST) Q3 Profit Surges
↗
August 04, 2025
Via
The Motley Fool
Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat
↗
August 04, 2025
Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall.
Via
Chartmill
Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results
August 04, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model
July 31, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
July 24, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025
July 14, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format
July 07, 2025
From
Twist Bioscience Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
